|
|
| Product Name: | LP-6 | | Synonyms: | LP-6;1H-Imidazole-2-butanamide, 4-(2,5-difluorophenyl)-N-[2-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)ethyl]-γ-[[[(3S,4R)-4-fluoro-3-pyrrolidinyl]methyl][(2S)-2-hydroxy-1-oxopropyl]amino]-β,β-dimethyl-1-(phenylmethyl)-, (γR)- | | CAS: | 1629736-79-3 | | MF: | | | MW: | 694.74 | | EINECS: | | | Product Categories: | | | Mol File: | 1629736-79-3.mol |  |
| Boiling point | 883.985±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.356±0.14 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 13.518±0.20(predicted) |
| Uses | LP-6 is a Drug-Linker Conjugates for ADC, and can be used for synthesis of ADCs. LP-6 consists of an Eg5 inhibitor and a linker[1]. | | References | [1] Karpov AS, et al. Discovery of Potent and Selective Antibody-Drug Conjugates with Eg5 Inhibitors through Linker and Payload Optimization. ACS Med Chem Lett. 2019 Dec 3;10(12):1674-1679. DOI:10.1021/acsmedchemlett.9b00468 |
| | LP-6 Preparation Products And Raw materials |
|
|
Tag:LP-6(1629736-79-3)
Related Product Information
|
|
Acetamide, N-[(3S)-3-amino-4-fluorobutyl]-N-[(1R)-1-[4-(2,5-difluorophenyl)-1-(phenylmethyl)-1H-imidazol-2-yl]-2,2-dimethylpropyl]-2-hydroxy-
LP-6
Eg5-IN-2
Glycinamide, N-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]glycylglycyl-L-phenylalanyl-N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3',4':6,7]indolizino[1,2-b]quinolin-1-yl]-
CL2A-SN-38
L-Ornithinamide, N6-[39-[bis(1-deoxy-D-glucitol-1-yl)amino]-1-oxo-4,7,10,13,16,19,22,25,28,31,34,37-dodecaoxanonatriacont-1-yl]-N2-[6-(2,5-dihydro-2,5-dioxo-1H-pyrrol-1-yl)-1-oxohexyl]-L-lysyl-L-valyl-N5-(aminocarbonyl)-N-[4-[[[[[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-1...
|